SD Biosensor KRX:137310KOSPI

에스디바이오센서 · Korean news coverage and regulatory filings, organized.

Articles, 24h4
Articles, 7 days6
DART filings, 7 days0
Articles tracked6since Sep 11

In Q2 2026, SD Biosensor reported revenue of ₩186bn, up 12.0% year on year, and an operating loss of ₩7.3bn. SD Biosensor (에스디바이오센서) appeared in 6 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 6 articles. It was most often mentioned alongside i-SENS.

SD Biosensor quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩186bn+12.0%−₩7.3bn₩16.3bn
Q1 2026₩194bn+4.4%−₩11.6bn₩22.3bn
Q4 2025 derived₩195bn+8.0%−₩31.8bn−₩760bn
Q3 2025₩164bn-3.8%−₩14.0bn−₩9.9bn
Q2 2025₩167bn-0.6%−₩20.6bn₩275bn
Q1 2025₩185bn+5.1%−₩14.6bn−₩18.8bn
Q4 2024 derived₩180bn+12.8%−₩18.1bn−₩134bn
Q3 2024₩171bn+13.0%−₩10.5bn₩65.2bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

SD Biosensor top stories 2 weeks, by number of outlets

  1. 1
    에스디바이오센서, '2026 대한민국 일자리 으뜸기업' 선정
    4 outlets · 4 articlesFirst report Sep 14 09:52 머니투데이
  2. 2
  3. 3

Latest SD Biosensor news Korean headlines